ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

SCORT-Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo.

Zhifen Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.